** Atomo Diagnostics AT1.AX soars as much as 11.1% to A$0.020; biggest intraday gain since Dec. 5, 2024
** Medical devices maker executes new long-term supply agreement for its HIV self-test device
** Five-year deal with existing distribution partner Newfoundland Diagnostics worth ~A$5.4 mln ($3.4 mln)
** Deal grants Newfoundland exclusive distribution rights to supply Atomo's test in the UK and non-exclusive rights for the EU and Colombia
** AT1 up 5.3% YTD
($1 = A$1.6184)
(Reporting by Adwitiya Srivastava in Bengaluru)
((Adwitiya.Srivastava@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。